5-[(PIPERAZIN-1-YL)-3-OXO-PROPYL]-IMIDAZOLIDINE-2,4-Dione Derivatives as Adamts Inhibitors for the Treatment of Osteoarthritis
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application PCT/EP2015/080430, filed Dec 18, 2015. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,926,281 | 5-[(PIPERAZIN-1-YL)-3-OXO-PROPYL]-IMIDAZOLIDINE-2,4-Dione Derivatives as Adamts Inhibitors for the Treatment of Osteoarthritis In force · High confidence UsedRemaining | Lakefront Biotherapeutics | In force | High confidence | ||
| US 10,487,060 | 5-[(PIPERAZIN-1-YL)-3-OXO-PROPYL]-IMIDAZOLIDINE-2,4-Dione Derivatives as Adamts Inhibitors for the Treatment of Osteoarthritis In force · High confidence | Lakefront Biotherapeutics | In force | High confidence | ||
| US 10,941,117 | 5-[(PIPERAZIN-1-YL)-3-OXO-PROPYL]-IMIDAZOLIDINE-2,4-Dione Derivatives as Adamts Inhibitors for the Treatment of Osteoarthritis In force · High confidence | Lakefront Biotherapeutics | In force | High confidence | ||
| US 11,718,588 | 5-[(PIPERAZIN-1-YL)-3-OXO-PROPYL]-IMIDAZOLIDINE-2,4-Dione Derivatives as Adamts Inhibitors for the Treatment of Osteoarthritis In force · High confidence | Lakefront Biotherapeutics | In force | High confidence |
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.